Dense Breast Tissue Screening Provides Early Detection - KTVN Channel 2 - Reno Tahoe Sparks News, Weather, Video

Dense Breast Tissue Screening Provides Early Detection

Posted: Updated:

From PrimeHealthcare:

Saint Mary's Regional Medical Center now offers the region's only FDA approved technology to screen for dense breast tissue. Automated Breast Ultrasound System (ABUS) is specifically designed to assist providers in finding cancerous tissue that may be hidden in dense breast tissue, something a traditional mammography can miss.
 
"This technology will be extremely beneficial for our patients and the early detection of cancer," said Steve Sweet, director of Imaging Services at Saint Mary's. "Providing our community with a new screening option will give women a sense of ease knowing there is a technology that can identify cancerous dense breast tissue."
 
With nearly 40 percent of women having dense breast tissue, it is believed that they have a greater risk of developing cancer than women who do not have dense breast tissue. While mammography remains the golden standard for early detection, finding cancers in women with dense breast tissue can be limited with mammography alone. Breast density is one of the strongest predictors of the limitations of mammography screening to detect cancer. That is why an ABUS screening is recommended in conjunction with a mammography for women with dense breast tissue. There are many factors that influence breast density including age, hormone levels, genetics, age at first pregnancy and number of pregnancies, use of hormone replacement therapy and overall body weight – to name a few.
 
ABUS screening, as a complement to traditional mammography, provides a clearer image of the breast tissue so a provider may better differentiate healthy and cancerous tissue. Unlike mammography, ABUS screening uses sound waves to create 3D pictures of the breast. There are also many benefits to utilizing ABUS screening. The scanning process is efficient and is a more comfortable option for patients compared to other scanning devices. The full screening takes less than 15 minutes providing doctors with state-of-the-art 3D images in minutes. Additionally, ABUS is covered by most insurance providers making it an affordable option for those with dense breast tissue.
 
For more information about ABUS screening and to find out if you have dense breast tissue, call 775-770-3187 or visit saintmarysreno.com. 

From PrimeHealthcare

  • Kristen Remington's Health Watch ReportsMore>>

  • KTVN's 10th Annual 'Give 2 Live' Blood Drive July 12

    KTVN's 10th Annual 'Give 2 Live' Blood Drive July 12

    Wednesday, June 28 2017 9:30 AM EDT2017-06-28 13:30:04 GMT

    In less than a month you can help save a life by giving blood. Our 10th annual Give 2 Live Blood Drive is coming up on Wednesday, July 12th.

    More >>

    In less than a month you can help save a life by giving blood. Our 10th annual Give 2 Live Blood Drive is coming up on Wednesday, July 12th.

    More >>
  • Ingredient in Popular Weed Killer Going on List as Cancerous

    Ingredient in Popular Weed Killer Going on List as Cancerous

    Tuesday, June 27 2017 5:06 PM EDT2017-06-27 21:06:42 GMT

    Officials announced that starting July 7 the weed killer's main ingredient, glyphosate, will appear on a list California keeps of potentially cancerous chemicals.

    More >>

    Officials announced that starting July 7 the weed killer's main ingredient, glyphosate, will appear on a list California keeps of potentially cancerous chemicals.

    More >>
  • Merck Says New Type of Cholesterol Drug Worked in Big Study

    Merck Says New Type of Cholesterol Drug Worked in Big Study

    Tuesday, June 27 2017 3:01 PM EDT2017-06-27 19:01:15 GMT

    Merck & Co. said Tuesday that a new type of cholesterol drug reduced heart attacks, deaths and other complications of heart disease in a huge, late-stage study. The positive result was a welcome surprise because three previous experimental drugs of the same type had failed. 

    More >>

    Merck & Co. said Tuesday that a new type of cholesterol drug reduced heart attacks, deaths and other complications of heart disease in a huge, late-stage study. The positive result was a welcome surprise because three previous experimental drugs of the same type had failed. 

    More >>
Powered by Frankly
All content © Copyright 2000 - 2017 Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.